Carcinogenesis of the oral cavity: Environmental causes and potential prevention by black raspberry

Chemical Research in Toxicology

Volumn 30, Issue 1, 2017, Pages 126-144

  El Bayoumy, Karam ^a   Chen, Kun Ming ^a   Zhang, Shang Min ^b   Sun, Yuan Wan ^a   Amin, Shantu ^a   Stoner, Gary ^c   Guttenplan, Joseph B ^d  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; 7,12 DIMETHYBENZ[A]ANTHRACENE; 7,12 DIMETHYLBENZ[A]ANTHRACENE; BENZO[A]PYRENE; BENZ[A]ANTHRACENE DERIVATIVE; CARCINOGEN; DIBENZO[A,L]PYRENE; EPOXIDE; NITROSONORNICOTINE; PLANT EXTRACT; TOBACCO SMOKE; UNCLASSIFIED DRUG; DNA ADDUCT; PROTEIN P53;

ANIMAL MODEL; CANCER PREVENTION; CARCINOGENESIS; DNA ADDUCT; DNA BINDING; DNA DAMAGE; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION; GENE MUTATION; HUMAN; METABOLIC ACTIVATION; MOUTH CANCER; MOUTH SQUAMOUS CELL CARCINOMA; MUTAGENESIS; NONHUMAN; RASPBERRY; REVIEW; RISK ASSESSMENT; SIGNAL TRANSDUCTION; TRANSGENIC ANIMAL; XENOGRAFT; ANIMAL; DISEASE MODEL; DNA REPAIR; GENETICS; METABOLISM; MOUTH NEOPLASMS; MUTATION; RUBUS;

ACTIVATION, METABOLIC; ANIMALS; CARCINOGENESIS; CARCINOGENS; DISEASE MODELS, ANIMAL; DNA ADDUCTS; DNA REPAIR; HUMANS; MOUTH NEOPLASMS; MUTATION; PLANT EXTRACTS; RUBUS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 85015142918     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/acs.chemrestox.6b00306     Document Type: Review

References (187)

1. Tanaka, T., and Ishigamori, R. (2011) Understanding carcino-genesis for fighting oral cancer. J. Oncol., Vol. 2011, DOI: 10.1155/2011/603740
2. Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet-Tieulent, J., and Jemal, A. (2015) Global cancer statistics, 2012. Ca-Cancer J. Clin. 65(2), 87-108.
3. Hsu, S., Singh, B., and Schuster, G. (2004) Induction of apoptosis in oral cancer cells: agents and mechanisms for potential therapy and prevention. Oral Oncol. 40(5), 461-73.
4. Parkin, D. M., Bray, F., Ferlay, J., and Pisani, P. (2005) Global cancer statistics, 2002. Ca-Cancer J. Clin. 55(2), 74-108.
5. Siegel, R. L., Miller, K. D., and Jemal, A. (2016) Cancer statistics. Ca-Cancer J. Clin. 66(1), 7-30.
6. Canto, M. T., and Devesa, S. S. (2002) Oral cavity and pharynx cancer incidence rates in the United States, 1975-1998. Oral Oncol. 38(6), 610-7.
7. Petersen, P. E. (2009) Oral cancer prevention and control-the approach of the World Health Organization. Oral Oncol. 45(4-5), 454-60.
8. Groome, P. A., Rohland, S. L., Hall, S. F., Irish, J., Mackillop, W. J., and O'Sullivan, B. (2011) A population-based study of factors associated with early versus late stage oral cavity cancer diagnoses. Oral Oncol. 47(7), 642-7.
9. Argiris, A., Karamouzis, M. V., Raben, D., and Ferris, R. L. (2008) Head and neck cancer. Lancet 371(9625), 1695-709.
10. da Silva, S. D., Hier, M., Mlynarek, A., Kowalski, L. P., and Alaoui-Jamali, M. A. (2012) Recurrent oral cancer: current and emerging therapeutic approaches. Front. Pharmacol. 3, 149.
11. Shah, F. D., Begum, R., Vajaria, B. N., Patel, K. R., Patel, J. B., Shukla, S. N., and Patel, P. S. (2011) A review on salivary genomics and proteomics biomarkers in oral cancer. Indian J. Clin. Biochem. 26(4), 326-34.
12. Gillison, M. L., Chaturvedi, A. K., Anderson, W. F., and Fakhry, C. (2015) Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma. J. Clin. Oncol. 33(29), 3235-42.
13. Chaturvedi, A. K., Engels, E. A., Pfeiffer, R. M., Hernandez, B. Y., Xiao, W., Kim, E., Jiang, B., Goodman, M. T., Sibug-Saber, M., Cozen, W., Liu, L., Lynch, C. F., Wentzensen, N., Jordan, R. C., Altekruse, S., Anderson, W. F., Rosenberg, P. S., and Gillison, M. L. (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J. Clin. Oncol. 29(32), 4294-301.
14. Ang, K. K., Harris, J., Wheeler, R., Weber, R., Rosenthal, D. I., Nguyen-Tan, P. F., Westra, W. H., Chung, C. H., Jordan, R. C., Lu, C., Kim, H., Axelrod, R., Silverman, C. C., Redmond, K. P., and Gillison, M. L. (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N. Engl. J. Med. 363(1), 24-35.
15. D'Souza, G., Kreimer, A. R., Viscidi, R., Pawlita, M., Fakhry, C., Koch, W. M., Westra, W. H., and Gillison, M. L. (2007) Case-control study of human papillomavirus and oropharyngeal cancer. N. Engl. J. Med. 356(19), 1944-56.
16. Herrero, R., Quint, W., Hildesheim, A., Gonzalez, P., Struijk, L., Katki, H. A., Porras, C., Schiffman, M., Rodriguez, A. C., Solomon, D., Jimenez, S., Schiller, J. T., Lowy, D. R., van Doorn, L. J., Wacholder, S., Kreimer, A. R., and Group, C. V. T. V. (2013) Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS One 8(7), e68329.
17. Mehanna, H., Beech, T., Nicholson, T., El-Hariry, I., McConkey, C., Paleri, V., and Roberts, S. (2013) Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region. Head & neck 35(5), 747-55.
18. Lingen, M. W., Xiao, W., Schmitt, A., Jiang, B., Pickard, R., Kreinbrink, P., Perez-Ordonez, B., Jordan, R. C., and Gillison, M. L. (2013) Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. Oral Oncol. 49(1), 1-8.
19. Saman, D. M. (2012) A review of the epidemiology of oral and pharyngeal carcinoma: update. Head Neck Oncol. 4, 1.
20. IARC (2007) Smokeless Tobacco and Some Tobacco-Specific N-Nitrosamines, Vol. 89, International Agency for Research on Cancer, Lyon, France.
21. Radoi, L., and Luce, D. (2013) A review of risk factors for oral cavity cancer: the importance of a standardized case definition. Community dentistry and oral epidemiology 41(2), 97-109 e78-91..
22. Warnakulasuriya, S. (2009) Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 45(4-5), 309-16.
23. Bradshaw, P. T., Siega-Riz, A. M., Campbell, M., Weissler, M. C., Funkhouser, W. K., and Olshan, A. F. (2012) Associations between dietary patterns and head and neck cancer: the Carolina head and neck cancer epidemiology study. Am. J. Epidemiol. 175(12), 1225-33.
24. Mognetti, B., Di Carlo, F., and Berta, G. N. (2006) Animal models in oral cancer research. Oral Oncol. 42(5), 448-60.
25. Kim, S. (2009) Animal models of cancer in the head and neck region. Clin. Exp. Otorhinolaryngol. 2(2), 55-60.
26. Sano, D., and Myers, J. N. (2009) Xenograft models of head and neck cancers. Head Neck Oncol. 1, 32.
27. Hanahan, D., and Weinberg, R. A. (2011) Hallmarks of cancer: the next generation. Cell 144(5), 646-74.
28. Kim, S. (2009) Animal models of cancer in the head and neck region. Clin. Exp. Otorhinolaryngol. 2(2), 55-60.
29. Li, H., Wheeler, S., Park, Y., Ju, Z., Thomas, S. M., Fichera, M., Egloff, A. M., Lui, V. W., Duvvuri, U., Bauman, J. E., Mills, G. B., and Grandis, J. R. (2016) Proteomic Characterization of Head and Neck Cancer Patient-Derived Xenografts. Mol. Cancer Res. 14(3), 278-86.
30. Siolas, D., and Hannon, G. J. (2013) Patient-derived tumor xenografts: transforming clinical samples into mouse models. Cancer Res. 73(17), 5315-9.
31. Lodhia, K. A., Hadley, A. M., Haluska, P., and Scott, C. L. (2015) Prioritizing therapeutic targets using patient-derived xenograft models. Biochim. Biophys. Acta, Rev. Cancer 1855(2), 223-34.
32. Raimondi, A. R., Vitale-Cross, L., Amornphimoltham, P., Gutkind, J. S., and Molinolo, A. (2006) Rapid development of salivary gland carcinomas upon conditional expression of K-ras driven by the cytokeratin 5 promoter. Am. J. Pathol. 168(5), 1654-65.
33. Vitale-Cross, L., Amornphimoltham, P., Fisher, G., Molinolo, A. A., and Gutkind, J. S. (2004) Conditional expression of K-ras in an epithelial compartment that includes the stem cells is sufficient to promote squamous cell carcinogenesis. Cancer Res. 64(24), 8804-7.
34. Vitale-Cross, L., Czerninski, R., Amornphimoltham, P., Patel, V., Molinolo, A. A., and Gutkind, J. S. (2009) Chemical carcinogenesis models for evaluating molecular-targeted prevention and treatment of oral cancer. Cancer Prev. Res. 2(5), 419-22.
35. Salley, J. J. (1954) Experimental carcinogenesis in the cheek pouch of the Syrian hamster. J. Dent. Res. 33(2), 253-62.
36. Morris, A. L. (1961) Factors influencing experimental carcinogensis in the hamster cheek pouch. J. Dent. Res. 40, 3-15.
37. Wallenius, K., and Lekholm, U. (1973) Oral cancer in rats induced by the water-soluble carcinogen 4-nitrochinoline N-oxide. Odontol. Revy 24(1), 39-48.
38. Tang, X. H., Knudsen, B., Bemis, D., Tickoo, S., and Gudas, L. J. (2004) Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice. Clin. Cancer Res. 10(1), 301-13.
39. El-Bayoumy, K., Chung, F. L., Richie, J., Jr., Reddy, B. S., Cohen, L., Weisburger, J., and Wynder, E. L. (1997) Dietary control of cancer. Proc. Soc. Exp. Biol. Med. 216(2), 211-23.
40. Gimenez-Conti, I. B., Bianchi, A. B., Stockman, S. L., Conti, C. J., and Slaga, T. J. (1992) Activating mutation of the Ha-ras gene in chemically induced tumors of the hamster cheek pouch. Mol. Carcinog. 5(4), 259-63.
41. Wong, D. T., Todd, R., Tsuji, T., and Donoff, R. B. (1996) Molecular biology of human oral cancer. Crit. Rev. Oral Biol. Med. 7(4), 319-28.
42. El-Bayoumy, K., Chung, F. L., Richie, J., Jr., Reddy, B. S., Cohen, L., Weisburger, J., and Wynder, E. L. (1997) Dietary control of cancer. Exp. Biol. Med. (London, U. K.) 216(2), 211-23.
43. Hecht, S. S., and Hoffmann, D. (1989) The relevance of tobacco-specific nitrosamines to human cancer. Cancer Surveys 8(2), 273-94.
44. Ng, S. K., Kabat, G. C., and Wynder, E. L. (1993) Oral cavity cancer in non-users of tobacco. Journal of the National Cancer Institute 85(9), 743-5.
45. Culp, S. J., Gaylor, D. W., Sheldon, W. G., Goldstein, L. S., and Beland, F. A. (1998) A comparison of the tumors induced by coal tar and benzo[a]pyrene in a 2-year bioassay. Carcinogenesis 19(1), 117-24.
46. Rao, A. R. (1984) Modifying influences of betel quid ingredients on B (a) P-induced carcinogenesis in the buccal pouch of hamster. Int. J. Cancer 33(5), 581-6.
47. Castonguay, A., Rivenson, A., Trushin, N., Reinhardt, J., Spathopoulos, S., Weiss, C. J., Reiss, B., and Hecht, S. S. (1984) Effects of chronic ethanol consumption on the metabolism and carcinogenicity of N'-nitrosonornicotine in F344 rats. Cancer research 44(6), 2285-90.
48. Hecht, S. S., Rivenson, A., Braley, J., DiBello, J., Adams, J. D., and Hoffmann, D. (1986) Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff. Cancer Res. 46(8), 4162-6.
49. Balbo, S., James-Yi, S., Johnson, C. S., O'Sullivan, M. G., Stepanov, I., Wang, M., Bandyopadhyay, D., Kassie, F., Carmella, S., Upadhyaya, P., and Hecht, S. S. (2013) (S)-N'-Nitrosonornicotine, a constituent of smokeless tobacco, is a powerful oral cavity carcinogen in rats. Carcinogenesis 34(9), 2178-83.
50. Guttenplan, J. B., Kosinska, W., Zhao, Z. L., Chen, K. M., Aliaga, C., DelTondo, J., Cooper, T., Sun, Y. W., Zhang, S. M., Jiang, K., Bruggeman, R., Sharma, A. K., Amin, S., Ahn, K., and El-Bayoumy, K. (2012) Mutagenesis and carcinogenesis induced by dibenzo[a, l]pyrene in the mouse oral cavity: a potential new model for oral cancer. Int. J. Cancer 130(12), 2783-90.
51. Mumford, J. L., Harris, D. B., Williams, K., Chuang, J. C., and Cooke, M. (1987) Indoor air sampling and mutagenicity studies of emissions from unvented coal combustion. Environ. Sci. Technol. 21(3), 308-11.
52. Tong, H. Y., and Karasek, F. W. (1984) Quantitation of polycyclic aromatic hydrocarbons in diesel exhaust particulate matter by high-performance liquid chromatography fractionation and high-resolution gas chromatography. Anal. Chem. 56(12), 2129-34.
53. Smith, C. J., and Hansch, C. (2000) The relative toxicity of compounds in mainstream cigarette smoke condensate. Food Chem. Toxicol. 38(7), 637-46.
54. Chen, K. M., Guttenplan, J. B., Zhang, S. M., Aliaga, C., Cooper, T. K., Sun, Y. W., DelTondo, J., Kosinska, W., Sharma, A. K., Jiang, K., Bruggeman, R., Ahn, K., Amin, S., and El-Bayoumy, K. (2013) Mechanisms of oral carcinogenesis induced by dibenzo[a, l]pyrene: an environmental pollutant and a tobacco smoke constituent. Int. J. Cancer 133(6), 1300-9.
55. Luch, A. (2009) On the impact of the molecule structure in chemical carcinogenesis. EXS 99, 151-79.
56. Hoffmann, D., Hoffmann, I., and El-Bayoumy, K. (2001) The less harmful cigarette: a controversial issue. a tribute to Ernst L. Wynder. Chemical research in toxicology. Chem. Res. Toxicol. 14(7), 767-90.
57. Stepanov, I., Villalta, P. W., Knezevich, A., Jensen, J., Hatsukami, D., and Hecht, S. S. (2010) Analysis of 23 polycyclic aromatic hydrocarbons in smokeless tobacco by gas chromatography-mass spectrometry. Chem. Res. Toxicol. 23(1), 66-73.
58. Kozin, I. S., Gooijer, C., and Velthorst, N. H. (1995) Direct Determination of Dibenzo[a, l]pyrene in Crude Extracts of Environmental Samples by Laser-Excited Shpol'skii Spectroscopy. Anal. Chem. 67, 1623-1626.
59. IARC (2010) Some Heterocyclic Polycyclic Aromatic Hydrocarbons and Some Related Exposures, Vol. 92, International Agency for Research on Cancer, Lyon, France.
60. Straif, K., Baan, R., Grosse, Y., Secretan, B., El Ghissassi, F., and Cogliano, V. (2005) Carcinogenicity of polycyclic aromatic hydrocarbons. Lancet Oncol. 6(12), 931-2.
61. Conney, A. H. (1982) Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. Cancer Res. 42(12), 4875-917.
62. Gelboin, H. V. (1980) Benzo[alpha]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiol. Rev. 60(4), 1107-66.
63. Shimada, T., Martin, M. V., Pruess-Schwartz, D., Marnett, L. J., and Guengerich, F. P. (1989) Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo (a) pyrene, 7, 8-dihydroxy-7, 8-dihydrobenzo (a) pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons. Cancer research 49(22), 6304-12.
64. Shimada, T., Hayes, C. L., Yamazaki, H., Amin, S., Hecht, S. S., Guengerich, F. P., and Sutter, T. R. (1996) Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res. 56(13), 2979-84.
65. Shimada, T., Yamazaki, H., Mimura, M., Wakamiya, N., Ueng, Y. F., Guengerich, F. P., and Inui, Y. (1996) Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs. Drug Metab. Dispos. 24(5), 515-22.
66. Shimada, T., Gillam, E. M., Oda, Y., Tsumura, F., Sutter, T. R., Guengerich, F. P., and Inoue, K. (1999) Metabolism of benzo[a]pyrene to trans-7, 8-dihydroxy-7, 8-dihydrobenzo[a]pyrene by recombinant human cytochrome P450 1B1 and purified liver epoxide hydrolase. Chem. Res. Toxicol. 12(7), 623-9.
67. Jennette, K. W., Jeffrey, A. M., Blobstein, S. H., Beland, F. A., Harvey, R. G., and Weinstein, I. B. (1977) Nucleoside adducts from the in vitro reaction of benzo[a]pyrene-7, 8-dihydrodiol 9, 10-oxide or benzo[a]pyrene 4, 5-oxide with nucleic acids. Biochemistry 16(5), 932-8.
68. Koreeda, M., Moore, P. D., Wislocki, P. G., Levin, W., Yagi, H., and Jerina, D. M. (1978) Binding of benzo[a]pyrene 7, 8-diol-9, 10-epoxides to DNA, RNA, and protein of mouse skin occurs with high stereoselectivity. Science (Washington, DC, U. S.) 199(4330), 778-81.
69. Palackal, N. T., Burczynski, M. E., Harvey, R. G., and Penning, T. M. (2001) The ubiquitous aldehyde reductase (AKR1A1) oxidizes proximate carcinogen trans-dihydrodiols to o-quinones: potential role in polycyclic aromatic hydrocarbon activation. Biochemistry 40(36), 10901-10.
70. Palackal, N. T., Lee, S. H., Harvey, R. G., Blair, I. A., and Penning, T. M. (2002) Activation of polycyclic aromatic hydrocarbon trans-dihydrodiol proximate carcinogens by human aldo-keto reductase (AKR1C) enzymes and their functional overexpression in human lung carcinoma (A549) cells. J. Biol. Chem. 277(27), 24799-808.
71. Burczynski, M. E., Harvey, R. G., and Penning, T. M. (1998) Expression and characterization of four recombinant human dihydrodiol dehydrogenase isoforms: oxidation of trans-7, 8-dihydroxy-7, 8-dihydrobenzo[a]pyrene to the activated o-quinone metabolite benzo-[a]pyrene-7, 8-dione. Biochemistry 37(19), 6781-90.
72. Penning, T. M., Ohnishi, S. T., Ohnishi, T., and Harvey, R. G. (1996) Generation of reactive oxygen species during the enzymatic oxidation of polycyclic aromatic hydrocarbon trans-dihydrodiols catalyzed by dihydrodiol dehydrogenase. Chem. Res. Toxicol. 9(1), 84-92.
73. Balu, N., Padgett, W. T., Lambert, G. R., Swank, A. E., Richard, A. M., and Nesnow, S. (2004) Identification and characterization of novel stable deoxyguanosine and deoxyadenosine adducts of benzo[a]pyrene-7, 8-quinone from reactions at physiological pH. Chem. Res. Toxicol. 17(6), 827-38.
74. McCoull, K. D., Rindgen, D., Blair, I. A., and Penning, T. M. (1999) Synthesis and characterization of polycyclic aromatic hydrocarbon o-quinone depurinating N7-guanine adducts. Chem. Res. Toxicol. 12(3), 237-46.
75. Shou, M., Harvey, R. G., and Penning, T. M. (1993) Reactivity of benzo[a]pyrene-7, 8-dione with DNA. Evidence for the formation of deoxyguanosine adducts. Carcinogenesis 14(3), 475-82.
76. Huang, M., Blair, I. A., and Penning, T. M. (2013) Identification of stable benzo[a]pyrene-7, 8-dione-DNA adducts in human lung cells. Chem. Res. Toxicol. 26(5), 685-92.
77. Cerutti, P. A. (1985) Prooxidant states and tumor promotion. Science (Washington, DC, U. S.) 227(4685), 375-81.
78. Cavalieri, E. L., and Rogan, E. G. (1995) Central role of radical cations in metabolic activation of polycyclic aromatic hydrocarbons. Xenobiotica 25(7), 677-88.
79. Poeta, M. L., Manola, J., Goldwasser, M. A., Forastiere, A., Benoit, N., Califano, J. A., Ridge, J. A., Goodwin, J., Kenady, D., Saunders, J., Westra, W., Sidransky, D., and Koch, W. M. (2007) TP53 mutations and survival in squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 357(25), 2552-61.
80. Carmella, S. G., McIntee, E. J., Chen, M., and Hecht, S. S. (2000) Enantiomeric composition of N'-nitrosonornicotine and N'-nitro-soanatabine in tobacco. Carcinogenesis 21(4), 839-43.
81. Stepanov, I., Yershova, K., Carmella, S., Upadhyaya, P., and Hecht, S. S. (2013) Levels of (S)-N'-nitrosonornicotine in U. S. tobacco products. Nicotine Tob. Res. 15(7), 1305-10.
82. Lao, Y., Yu, N., Kassie, F., Villalta, P. W., and Hecht, S. S. (2007) Analysis of pyridyloxobutyl DNA adducts in F344 rats chronically treated with (R) - and (S)-N'-nitrosonornicotine. Chem. Res. Toxicol. 20(2), 246-56.
83. Zhang, S., Wang, M., Villalta, P. W., Lindgren, B. R., Upadhyaya, P., Lao, Y., and Hecht, S. S. (2009) Analysis of pyridyloxobutyl and pyridylhydroxybutyl DNA adducts in extrahepatic tissues of F344 rats treated chronically with 4-(methylnitrosamino)-1-(3-pyridyl)-1-buta-none and enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol. Chem. Res. Toxicol. 22(5), 926-36.
84. McIntee, E. J., and Hecht, S. S. (2000) Metabolism of N'-nitrosonornicotine enantiomers by cultured rat esophagus and in vivo in rats. Chem. Res. Toxicol. 13(3), 192-9.
85. Kanojia, D., and Vaidya, M. M. (2006) 4-nitroquinoline-1-oxide induced experimental oral carcinogenesis. Oral Oncol. 42(7), 655-67.
86. Dipple, A., Cheng, S. C., and Bigger, C. A. (1990) Polycyclic aromatic hydrocarbon carcinogens. Prog. Clin. Biol. Res. 347, 109-27.
87. El-Bayoumy, K., Chae, Y. H., Upadhyaya, P., Meschter, C., Cohen, L. A., and Reddy, B. S. (1992) Inhibition of 7, 12-dimethylbenz (a)-anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound, 1, 4-phenylenebis (methylene)-selenocyanate. Cancer Res. 52(9), 2402-7.
88. Casto, B. C., Kresty, L. A., Kraly, C. L., Pearl, D. K., Knobloch, T. J., Schut, H. A., Stoner, G. D., Mallery, S. R., and Weghorst, C. M. (2002) Chemoprevention of oral cancer by black raspberries. Anticancer Res. 22(6C), 4005-15.
89. Morisseau, C., and Hammock, B. D. (2005) Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles. Annu. Rev. Pharmacol. Toxicol. 45, 311-33.
90. Ralston, S. L., Lau, H. H., Seidel, A., Luch, A., Platt, K. L., and Baird, W. M. (1994) The potent carcinogen dibenzo[a, l]pyrene is metabolically activated to fjord-region 11, 12-diol 13, 14-epoxides in human mammary carcinoma MCF-7 cell cultures. Cancer Res. 54(4), 887-90.
91. Ralston, S. L., Seidel, A., Luch, A., Platt, K. L., and Baird, W. M. (1995) Stereoselective activation of dibenzo[a, l]pyrene to (-)-anti (11R, 12S, 13S, 14R) - and (+)-syn (11S, 12R, 13S, 14R)-11, 12-diol-13, 14-epoxides which bind extensively to deoxyadenosine residues of DNA in the human mammary carcinoma cell line MCF-7. Carcinogenesis 16(12), 2899-907.
92. Arif, J. M., and Gupta, R. C. (1997) Microsome-mediated bioactivation of dibenzo[a, l]pyrene and identification of DNA adducts by 32P-postlabeling. Carcinogenesis 18(10), 1999-2007.
93. Luch, A., Schober, W., Soballa, V. J., Raab, G., Greim, H., Jacob, J., Doehmer, J., and Seidel, A. (1999) Metabolic activation of dibenzo-[a, l]pyrene byhuman cytochrome P450 1A1 and P450 1B1 expressed in V79 Chinese hamster cells. Chem. Res. Toxicol. 12(4), 353-64.
94. Buters, J. T., Mahadevan, B., Quintanilla-Martinez, L., Gonzalez, F. J., Greim, H., Baird, W. M., and Luch, A. (2002) Cytochrome P450 1B1 determines susceptibility to dibenzo[a, l]pyrene-induced tumor formation. Chem. Res. Toxicol. 15(9), 1127-35.
95. Kleiner, H. E., Vulimiri, S. V., Hatten, W. B., Reed, M. J., Nebert, D. W., Jefcoate, C. R., and DiGiovanni, J. (2004) Role of cytochrome p4501 family members in the metabolic activation of polycyclic aromatic hydrocarbons in mouse epidermis. Chem. Res. Toxicol. 17(12), 1667-74.
96. Luch, A., Coffing, S. L., Tang, Y. M., Schneider, A., Soballa, V., Greim, H., Jefcoate, C. R., Seidel, A., Greenlee, W. F., Baird, W. M., and Doehmer, J. (1998) Stable expression of human cytochrome P450 1B1 in V79 Chinese hamster cells and metabolically catalyzed DNA adduct formation of dibenzo[a, l]pyrene. Chem. Res. Toxicol. 11(6), 686-95.
97. Mahadevan, B., Luch, A., Seidel, A., Pelling, J. C., and Baird, W. M. (2001) Effects of the (-)-anti-11R, 12S-dihydrodiol 13S, 14R-epoxide of dibenzo[a, l]pyrene on DNA adduct formation and cell cycle arrest in human diploid fibroblasts. Carcinogenesis 22(1), 161-9.
98. Shimada, T., and Fujii-Kuriyama, Y. (2004) Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. Cancer Sci. 95(1), 1-6.
99. Courter, L. A., Musafia-Jeknic, T., Fischer, K., Bildfell, R., Giovanini, J., Pereira, C., and Baird, W. M. (2007) Urban dust particulate matter alters PAH-induced carcinogenesis by inhibition of CYP1A1 and CYP1B1. Toxicol. Sci. 95(1), 63-73.
100. Seidel, A., Friedberg, T., Lollmann, B., Schwierzok, A., Funk, M., Frank, H., Holler, R., Oesch, F., and Glatt, H. (1998) Detoxification of optically active bay- and fjord-region polycyclic aromatic hydrocarbon dihydrodiol epoxides by human glutathione transferase P1-1 expressed in Chinese hamster V79 cells. Carcinogenesis 19(11), 1975-81.
101. Olson, K. C., Sun, D., Chen, G., Sharma, A. K., Amin, S., Ropson, I. J., Spratt, T. E., and Lazarus, P. (2011) Characterization of dibenzo[a, l]pyrene-trans-11, 12-diol (dibenzo[def, p]chrysene) glucuronidation by UDP-glucuronosyltransferases. Chem. Res. Toxicol. 24(9), 1549-59.
102. Xue, W., and Warshawsky, D. (2005) Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: a review. Toxicol. Appl. Pharmacol. 206(1), 73-93.
103. Dreij, K., Seidel, A., and Jernstrom, B. (2005) Differential removal of DNA adducts derived from anti-diol epoxides of dibenzo-[a, l]pyrene and benzo[a]pyrene in human cells. Chem. Res. Toxicol. 18(4), 655-64.
104. Zhang, S. M., Chen, K. M., Aliaga, C., Sun, Y. W., Lin, J. M., Sharma, A. K., Amin, S., and El-Bayoumy, K. (2011) Identification and quantification of DNA adducts in the oral tissues of mice treated with the environmental carcinogen dibenzo[a, l]pyrene by HPLC-MS/MS. Chem. Res. Toxicol. 24(8), 1297-303.
105. Szeliga, J., and Dipple, A. (1998) DNA adduct formation by polycyclic aromatic hydrocarbon dihydrodiol epoxides. Chem. Res. Toxicol. 11(1), 1-11.
106. Zhang, S. M., Chen, K. M., Sun, Y. W., Aliaga, C., Lin, J. M., Sharma, A. K., Amin, S., and El-Bayoumy, K. (2014) Simultaneous detection of deoxyadenosine and deoxyguanosine adducts in the tongue and other oral tissues of mice treated with Dibenzo[a, l]pyrene. Chem. Res. Toxicol. 27(7), 1199-206.
107. Melendez-Colon, V. J., Luch, A., Seidel, A., and Baird, W. M. (2000) Formation of stable DNA adducts and apurinic sites upon metabolic activation of bay and fjord region polycyclic aromatic hydrocarbons in human cell cultures. Chem. Res. Toxicol. 13(1), 10-7.
108. Mahadevan, B., Marston, C. P., Luch, A., Dashwood, W. M., Brooks, E., Pereira, C., Doehmer, J., and Baird, W. M. (2007) Competitive inhibition of carcinogen-activating CYP1A1 and CYP1B1 enzymes by a standardized complex mixture of PAH extracted from coal tar. Int. J. Cancer 120(6), 1161-8.
109. Nesnow, S., Davis, C., Nelson, G., Ross, J. A., Allison, J., Adams, L., and King, L. C. (1997) Comparison of the morphological transforming activities of dibenzo[a, l]pyrene and benzo[a]pyrene in C3H10T1/2CL8 cells and characterization of the dibenzo[a, l]pyrene-DNA adducts. Carcinogenesis 18(10), 1973-8.
110. Mahadevan, B., Luch, A., Bravo, C. F., Atkin, J., Steppan, L. B., Pereira, C., Kerkvliet, N. I., and Baird, W. M. (2005) Dibenzo[a, l]pyrene induced DNA adduct formation in lung tissue in vivo. Cancer Lett. 227(1), 25-32.
111. Sancar, A. (1996) DNA excision repair. Annu. Rev. Biochem. 65, 43-81.
112. Wood, R. D. (1999) DNA damage recognition during nucleotide excision repair in mammalian cells. Biochimie 81(1-2), 39-44.
113. Buterin, T., Hess, M. T., Luneva, N., Geacintov, N. E., Amin, S., Kroth, H., Seidel, A., and Naegeli, H. (2000) Unrepaired fjord region polycyclic aromatic hydrocarbon-DNA adducts in ras codon 61 mutational hot spots. Cancer Res. 60(7), 1849-56.
114. Cai, Y., Ding, S., Geacintov, N. E., and Broyde, S. (2011) Intercalative conformations of the 14R (+) - and 14S (-)-trans-anti-DB[a, l]P-N (6)-dA adducts: molecular modeling and MD simulations. Chem. Res. Toxicol. 24(4), 522-31.
115. Kropachev, K., Kolbanovskiy, M., Liu, Z., Cai, Y., Zhang, L., Schwaid, A. G., Kolbanovskiy, A., Ding, S., Amin, S., Broyde, S., and Geacintov, N. E. (2013) Adenine-DNA adducts derived from the highly tumorigenic Dibenzo[a, l]pyrene are resistant to nucleotide excision repair while guanine adducts are not. Chem. Res. Toxicol. 26(5), 783-93.
116. Roth, R. B., Amin, S., Geacintov, N. E., and Scicchitano, D. A. (2001) Bacteriophage T7 RNA polymerase transcription elongation is inhibited by site-specific, stereospecific benzo[c]phenanthrene diol epoxide DNA lesions. Biochemistry 40(17), 5200-7.
117. Ruan, Q., Kolbanovskiy, A., Zhuang, P., Chen, J., Krzeminski, J., Amin, S., and Geacintov, N. E. (2002) Synthesis and characterization of site-specific and stereoisomeric fjord dibenzo[a, l]pyrene diol epoxide-N (6)-adenine adducts: unusual thermal stabilization of modified DNA duplexes. Chem. Res. Toxicol. 15(2), 249-61.
118. Spencer, W. A., Singh, J., and Orren, D. K. (2009) Formation and differential repair of covalent DNA adducts generated by treatment of human cells with (±)-anti-dibenzo[a, l]pyrene-11, 12-diol-13, 14-epox-ide. Chem. Res. Toxicol. 22(1), 81-9.
119. Prahalad, A. K., Ross, J. A., Nelson, G. B., Roop, B. C., King, L. C., Nesnow, S., and Mass, M. J. (1997) Dibenzo[a, l]pyrene-induced DNA adduction, tumorigenicity, and Ki-ras oncogene mutations in strain A/J mouse lung. Carcinogenesis 18(10), 1955-63.
120. Todorovic, R., Devanesan, P., Rogan, E., and Cavalieri, E. (2005) Identification and quantification of stable DNA adducts formed from dibenzo[a, l]pyrene or its metabolites in vitro and in mouse skin and rat mammary gland. Chem. Res. Toxicol. 18(6), 984-90.
121. Mahadevan, B., Dashwood, W. M., Luch, A., Pecaj, A., Doehmer, J., Seidel, A., Pereira, C., and Baird, W. M. (2003) Mutations induced by (-)-anti-11R, 12S-dihydrodiol 13S, 14R-epoxide of dibenzo[a, l]pyrene in the coding region of the hypoxanthine phosphoribosyltransferase (Hprt) gene in Chinese hamster V79 cells. Environ. Mol. Mutagen. 41(2), 131-9.
122. Yoon, J. H., Besaratinia, A., Feng, Z., Tang, M. S., Amin, S., Luch, A., and Pfeifer, G. P. (2004) DNA damage, repair, and mutation induction by (+)-Syn and (-)-anti-dibenzo[a, l]pyrene-11, 12-diol-13, 14-epoxides in mouse cells. Cancer Res. 64(20), 7321-8.
123. Booth, D. R. (1990) A relationship found between intra-oral sites of 4NQO reductase activity and chemical carcinogenesis. Cell Proliferation 23(4), 331-40.
124. von Pressentin, M. M., Kosinska, W., and Guttenplan, J. B. (1999) Mutagenesis induced by oral carcinogens in lacZ mouse (MutaMouse) tongue and other oral tissues. Carcinogenesis 20(11), 2167-70.
125. von Pressentin, M. M., Chen, M., and Guttenplan, J. B. (2001) Mutagenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-buta-none-4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N-nitro-sonornicotine in lacZ upper aerodigestive tissue and liver and inhibition by green tea. Carcinogenesis 22(1), 203-6.
126. Kosinska, W., von Pressentin, M. D., and Guttenplan, J. B. (1999) Mutagenesis induced by benzo[a]pyrene in lacZ mouse mammary and oral tissues: comparisons with mutagenesis in other organs and relationships to previous carcinogenicity assays. Carcino-genesis 20(6), 1103-6.
127. Lambert, I. B., Singer, T. M., Boucher, S. E., and Douglas, G. R. (2005) Detailed review of transgenic rodent mutation assays. Mutat. Res., Rev. Mutat. Res. 590(1-3), 1-280.
128. Hakura, A., Tsutsui, Y., Sonoda, J., Kai, J., Imade, T., Shimada, M., Sugihara, Y., and Mikami, T. (1998) Comparison between in vivo mutagenicity and carcinogenicity in multiple organs by benzo[a]pyrene in the lacZ transgenic mouse (Muta Mouse). Mutat. Res., Fundam. Mol. Mech. Mutagen. 398(1-2), 123-30.
129. Guttenplan, J. B., Spratt, T. E., Khmelnitsky, M., Kosinska, W., Desai, D., and El-Bayoumy, K. (2004) Effects of 3H-1, 2-dithiole-3-thione, 1, 4-phenylenebis (methylene) selenocyanate, and selenium-enriched yeast individually and in combination on benzo[a]pyrene-induced mutagenesis in oral tissue and esophagus in lacZ mice. Mutat. Res., Genet. Toxicol. Environ. Mutagen. 559(1-2), 199-210.
130. Fuller, C. D., Wang, S. J., Thomas, C. R., Jr., Hoffman, H. T., Weber, R. S., and Rosenthal, D. I. (2007) Conditional survival in head and neck squamous cell carcinoma: results from the SEER dataset 1973-1998. Cancer 109(7), 1331-43.
131. Hjortsberg, L., Rubio-Nevado, J., Hamroun, D., Claustres, M., Beroud, C., and Soussi, T. (2008) The p53 Mutation Handbook 2.0, http://p53.free.fr.
132. Denissenko, M. F., Pao, A., Tang, M., and Pfeifer, G. P. (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science (Washington, DC, U. S.) 274(5286), 430-2.
133. Klingelhofer, J., Senolt, L., Baslund, B., Nielsen, G. H., Skibshoj, I., Pavelka, K., Neidhart, M., Gay, S., Ambartsumian, N., Hansen, B. S., Petersen, J., Lukanidin, E., and Grigorian, M. (2007) Up-regulation of metastasis-promoting S100A4 (Mts-1) in rheumatoid arthritis: putative involvement in the pathogenesis of rheumatoid arthritis. Arthritis Rheum. 56(3), 779-89.
134. Bruno, T., De Nicola, F., Iezzi, S., Lecis, D., D'Angelo, C., Di Padova, M., Corbi, N., Dimiziani, L., Zannini, L., Jekimovs, C., Scarsella, M., Porrello, A., Chersi, A., Crescenzi, M., Leonetti, C., Khanna, K. K., Soddu, S., Floridi, A., Passananti, C., Delia, D., and Fanciulli, M. (2006) Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint. Cancer Cell 10(6), 473-86.
135. Stott, F. J., Bates, S., James, M. C., McConnell, B. B., Starborg, M., Brookes, S., Palmero, I., Ryan, K., Hara, E., Vousden, K. H., and Peters, G. (1998) The alternative product from the human CDKN2A locus, p14 (ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17(17), 5001-14.
136. Hong, S., Pusapati, R. V., Powers, J. T., and Johnson, D. G. (2006) Oncogenes and the DNA damage response: Myc and E2F1 engage the ATM signaling pathway to activate p53 and induce apoptosis. Cell Cycle 5(8), 801-3.
137. Sperka, T., Wang, J., and Rudolph, K. L. (2012) DNA damage checkpoints in stem cells, ageing and cancer. Nat. Rev. Mol. Cell Biol. 13(9), 579-90.
138. Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., and Green, D. R. (2004) Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science (Washington, DC, U. S.) 303(5660), 1010-4.
139. Takimoto, R., Wang, W., Dicker, D. T., Rastinejad, F., Lyssikatos, J., and el-Deiry, W. S. (2002) The mutant p53-conformation modifying drug, CP-31398, can induce apoptosis of human cancer cells and can stabilize wild-type p53 protein. Cancer Biol. Ther. 1(1), 47-55.
140. Shetty, S., Shetty, P., Idell, S., Velusamy, T., Bhandary, Y. P., and Shetty, R. S. (2008) Regulation of plasminogen activator inhibitor-1 expression by tumor suppressor protein p53. J. Biol. Chem. 283(28), 19570-80.
141. Bodvarsdottir, S. K., Steinarsdottir, M., Hilmarsdottir, H., Jonasson, J. G., and Eyfjord, J. E. (2007) MYC amplification and TERT expression in breast tumor progression. Cancer Genet. Cytogenet. 176(2), 93-9.
142. Blons, H., Pallier, K., Le Corre, D., Danel, C., Tremblay-Gravel, M., Houdayer, C., Fabre-Guillevin, E., Riquet, M., Dessen, P., and Laurent-Puig, P. (2008) Genome wide SNP comparative analysis between EGFR and KRAS mutated NSCLC and characterization of two models of oncogenic cooperation in non-small cell lung carcinoma. BMC Med. Genomics 1, 25.
143. Wei, X., Xu, H., and Kufe, D. (2005) Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response. Cancer Cell 7(2), 167-78.
144. Luo, J., Su, F., Chen, D., Shiloh, A., and Gu, W. (2000) Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 408(6810), 377-81.
145. Kekatpure, V. D., Bs, N., Wang, H., Zhou, X. K., Kandasamy, C., Sunny, S. P., Suresh, A., Milne, G. L., Kuriakose, M. A., and Dannenberg, A. J. (2016) Elevated Levels of Urinary PGE-M Are Found in Tobacco Users and Indicate a Poor Prognosis for Oral Squamous Cell Carcinoma Patients. Cancer Prev. Res. 9(6), 428-36.
146. Stoner, G. D., Wang, L. S., Zikri, N., Chen, T., Hecht, S. S., Huang, C., Sardo, C., and Lechner, J. F. (2007) Cancer prevention with freeze-dried berries and berry components. Semin. Cancer Biol. 17(5), 403-10.
147. Stoner, G. D. (2009) Foodstuffs for preventing cancer: the preclinical and clinical development of berries. Cancer Prev. Res. 2(3), 187-94.
148. Stoner, G. D., Sardo, C., Apseloff, G., Mullet, D., Wargo, W., Pound, V., Singh, A., Sanders, J., Aziz, R., Casto, B., and Sun, X. (2005) Pharmacokinetics of anthocyanins and ellagic acid in healthy volunteers fed freeze-dried black raspberries daily for 7 days. J. Clin. Pharmacol. 45(10), 1153-64.
149. Kresty, L. A., Frankel, W. L., Hammond, C. D., Baird, M. E., Mele, J. M., Stoner, G. D., and Fromkes, J. J. (2006) Transitioning from preclinical to clinical chemopreventive assessments of lyophilized black raspberries: interim results show berries modulate markers of oxidative stress in Barrett's esophagus patients. Nutr. Cancer 54(1), 148-56.
150. Mallery, S. R., Stoner, G. D., Larsen, P. E., Fields, H. W., Rodrigo, K. A., Schwartz, S. J., Tian, Q., Dai, J., and Mumper, R. J. (2007) Formulation and in-vitro and in-vivo evaluation of a mucoadhesive gel containing freeze dried black raspberries: implications for oral cancer chemoprevention. Pharm. Res. 24(4), 728-37.
151. Mallery, S. R., Tong, M., Shumway, B. S., Curran, A. E., Larsen, P. E., Ness, G. M., Kennedy, K. S., Blakey, G. H., Kushner, G. M., Vickers, A. M., Han, B., Pei, P., and Stoner, G. D. (2014) Topical application of a mucoadhesive freeze-dried black raspberry gel induces clinical and histologic regression and reduces loss of heterozygosity events in premalignant oral intraepithelial lesions: results from a multicentered, placebo-controlled clinical trial. Clin. Cancer Res. 20(7), 1910-24.
152. Ugalde, C. M., Liu, Z., Ren, C., Chan, K. K., Rodrigo, K. A., Ling, Y., Larsen, P. E., Chacon, G. E., Stoner, G. D., Mumper, R. J., Fields, H. W., and Mallery, S. R. (2009) Distribution of anthocyanins delivered from a bioadhesive black raspberry gel following topical intraoral application in normal healthy volunteers. Pharm. Res. 26(4), 977-86.
153. Shumway, B. S., Kresty, L. A., Larsen, P. E., Zwick, J. C., Lu, B., Fields, H. W., Mumper, R. J., Stoner, G. D., and Mallery, S. R. (2008) Effects of a topically applied bioadhesive berry gel on loss of heterozygosity indices in premalignant oral lesions. Clin. Cancer Res. 14(8), 2421-30.
154. Mallery, S. R., Zwick, J. C., Pei, P., Tong, M., Larsen, P. E., Shumway, B. S., Lu, B., Fields, H. W., Mumper, R. J., and Stoner, G. D. (2008) Topical application of a bioadhesive black raspberry gel modulates gene expression and reduces cyclooxygenase 2 protein in human premalignant oral lesions. Cancer Res. 68(12), 4945-57.
155. Knobloch, T. J., Uhrig, L. K., Pearl, D. K., Casto, B. C., Warner, B. M., Clinton, S. K., Sardo-Molmenti, C. L., Ferguson, J. M., Daly, B. T., Riedl, K., Schwartz, S. J., Vodovotz, Y., Buchta, A. J., Sr., Schuller, D. E., Ozer, E., Agrawal, A., and Weghorst, C. M. (2016) Suppression of Proinflammatory and Prosurvival Biomarkers in Oral Cancer Patients Consuming a Black Raspberry Phytochemical-Rich Troche. Cancer Prev. Res. 9(2), 159-71.
156. Wen, X., and Walle, T. (2005) Preferential induction of CYP1B1 by benzo[a]pyrene in human oral epithelial cells: impact on DNA adduct formation and prevention by polyphenols. Carcinogenesis 26(10), 1774-81.
157. Walle, T., Walle, U. K., Sedmera, D., and Klausner, M. (2006) Benzo[A]pyrene-induced oral carcinogenesis and chemoprevention: studies in bioengineered human tissue. Drug metabolism and disposition: the biological fate of chemicals 34(3), 346-50.
158. Calderon-Montano, J. M., Burgos-Moron, E., Perez-Guerrero, C., and Lopez-Lazaro, M. (2011) A review on the dietary flavonoid kaempferol. Mini-Rev. Med. Chem. 11(4), 298-344.
159. Chow, H. H., Garland, L. L., Hsu, C. H., Vining, D. R., Chew, W. M., Miller, J. A., Perloff, M., Crowell, J. A., and Alberts, D. S. (2010) Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study. Cancer Prev. Res. 3(9), 1168-75.
160. Bruno, R. D., and Njar, V. C. (2007) Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development. Bioorg. Med. Chem. 15(15), 5047-60.
161. Guttenplan, J., Chen, K. M., Sun, Y. W., Kosinska, W., Zhou, Y., Kim, S. A., Sung, Y., Gowda, K., Amin, S., Stoner, G., and El-Bayoumy, K. (2016) Effects of black raspberry extract and protocatechuic acid on carcinogen-DNA adducts and mutagenesis, and oxidative stress in rat and human oral cells. Cancer Prev. Res. 9(8), 704-12.
162. Hecht, S. S., Huang, C., Stoner, G. D., Li, J., Kenney, P. M., Sturla, S. J., and Carmella, S. G. (2006) Identification of cyanidin glycosides as constituents of freeze-dried black raspberries which inhibit anti-benzo[a]pyrene-7, 8-diol-9, 10-epoxide induced NFkappaB and AP-1 activity. Carcinogenesis 27(8), 1617-26.
163. Manach, C., Williamson, G., Morand, C., Scalbert, A., and Remesy, C. (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. AM. J. Clin. Nutr. 81(1), 230S-242S.
164. Ichiyanagi, T., Oikawa, K., Tateyama, C., and Konishi, T. (2001) Acid mediated hydrolysis of blueberry anthocyanins. Chem. Pharm. Bull. 49(1), 114-7.
165. Wu, S., Powers, S., Zhu, W., and Hannun, Y. A. (2016) Substantial contribution of extrinsic risk factors to cancer development. Nature 529(7584), 43-7.
166. Noble, R. J., Kaltz, O., Nunney, L., and Hochberg, M. E. (2016) Overestimating the role of environment in cancers. Cancer Prev. Res. 9, 773.
167. Stanford, E. A., Ramirez-Cardenas, A., Wang, Z., Novikov, O., Alamoud, K., Koutrakis, P., Mizgerd, J. P., Genco, C. A., Kukuruzinska, M., Monti, S., Bais, M. V., and Sherr, D. H. (2016) Role for the Aryl Hydrocarbon Receptor and Diverse Ligands In Oral Squamous Cell Carcinoma Migration and Tumorigenesis. Mol. Cancer Res. 14(8), 696-706.
168. Bais, M. V., Kukuruzinska, M., and Trackman, P. C. (2015) Orthotopic non-metastatic and metastatic oral cancer mouse models. Oral Oncol. 51(5), 476-82.
169. Hartmann, S., Bhola, N. E., and Grandis, J. R. (2016) HGF/Met Signaling in Head and Neck Cancer: Impact on the Tumor Microenvironment. Clin. Cancer Res. 22(16), 4005-4013.
170. Lin, D. T., Subbaramaiah, K., Shah, J. P., Dannenberg, A. J., and Boyle, J. O. (2002) Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer. Head & neck 24(8), 792-9.
171. Morton, R. S., and Dongari-Bagtzoglou, A. I. (2001) Cyclooxygenase-2 is upregulated in inflamed gingival tissues. J. Periodontol. 72(4), 461-9.
172. DeMarini, D. M., Hanley, N. M., Warren, S. H., Adams, L. D., and King, L. C. (2011) Association between mutation spectra and stable and unstable DNA adduct profiles in Salmonella for benzo[a]pyrene and dibenzo[a, l]pyrene. Mutat. Res., Fundam. Mol. Mech. Mutagen. 714(1-2), 17-25.
173. Altuwairgi, O. S., Papageorge, M. B., and Doku, H. C. (1995) The cancer-promoting effect of N-nitrosonornicotine used in combination with a subcarcinogenic dose of 4-nitroquinoline-N-oxide and 7, 12-dimethylbenz (A) anthracene. J. Oral Maxillofac Surg 53(8), 910-3 discussion, p 914..
174. Maurya, D. K., Salvi, V. P., and Nair, C. K. (2005) Radiation protection of DNA by ferulic acid under in vitro and in vivo conditions. Mol. Cell. Biochem. 280(1-2), 209-17.
175. Niture, S. K., Velu, C. S., Smith, Q. R., Bhat, G. J., and Srivenugopal, K. S. (2007) Increased expression of the MGMT repair protein mediated by cysteine prodrugs and chemopreventative natural products in human lymphocytes and tumor cell lines. Carcinogenesis 28(2), 378-89.
176. Pavanello, S., Bollati, V., Pesatori, A. C., Kapka, L., Bolognesi, C., Bertazzi, P. A., and Baccarelli, A. (2009) Global and gene-specific promoter methylation changes are related to anti-B[a]PDE-DNA adduct levels and influence micronuclei levels in polycyclic aromatic hydrocarbon-exposed individuals. Int. J. Cancer 125(7), 1692-7.
177. Barros, S. P., and Offenbacher, S. (2009) Epigenetics: connecting environment and genotype to phenotype and disease. J. Dent. Res. 88(5), 400-8.
178. Sharma, S., Kelly, T. K., and Jones, P. A. (2010) Epigenetics in cancer. Carcinogenesis 31(1), 27-36.
179. Tommasi, S., Zheng, A., Yoon, J. I., and Besaratinia, A. (2014) Epigenetic targeting of the Nanog pathway and signaling networks during chemical carcinogenesis. Carcinogenesis 35(8), 1726-36.
180. Hoffmann, D., Hoffmann, I., and El-Bayoumy, K. (2001) The less harmful cigarette: a controversial issue. a tribute to Ernst L. Wynder. Chem. Res. Toxicol. 14(7), 767-90.
181. El-Bayoumy, K. (1992) Environmental carcinogens that may be involved in human breast cancer etiology. Chem. Res. Toxicol. 5(5), 585-90.
182. Schwartz, J., Baker, V., Larios, E., Desai, D., and Amin, S. (2004) Inhibition of experimental tobacco carcinogen induced head and neck carcinogenesis. Oral Oncol. 40(6), 611-23.
183. Tanaka, T., Makita, H., Kawabata, K., Mori, H., and El-Bayoumy, K. (1997) 1, 4-phenylenebis (methylene) selenocyanate exerts exceptional chemopreventive activity in rat tongue carcinogenesis. Cancer Res. 57(17), 3644-8.
184. Bauman, J. E., Zang, Y., Sen, M., Li, C., Wang, L., Egner, P. A., Fahey, J. W., Normolle, D. P., Grandis, J. R., Kensler, T. W., and Johnson, D. E. (2016) Prevention of Carcinogen-Induced Oral Cancer by Sulforaphane. Cancer Prev. Res. 9(7), 547-57.
185. Shklar, G., and Schwartz, J. L. (1996) Vitamin E inhibits experimental carcinogenesis and tumour angiogenesis. Eur. J. Cancer 32B (2), 114-9.
186. Gorelick, N. J., Andrews, J. L., Gu, M., and Glickman, B. W. (1995) Mutational spectra in the lacl gene in skin from 7, 12-dimethylbenz[a]anthracene-treated and untreated transgenic mice. Mol. Carcinog. 14(1), 53-62.
187. Ryu, J., Youn, J., Kim, Y., Kwon, O., Song, Y., Kim, H., Cho, K., and Chang, I. (1999) Mutation spectrum of 4-nitroquinoline N-oxide in the lacI transgenic Big Blue Rat2 cell line. Mutat. Res., Genet. Toxicol. Environ. Mutagen. 445(1), 127-35.